| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Argentina | 4 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | Mexico | 2 | |
| #6 | United States | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | United Kingdom | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Implantable devices |
| # | Name | Total Patents |
|---|---|---|
| #1 | Scasso Alejandro Fabio | 10 |
| #2 | Forlano Paula | 5 |
| #3 | Stefano Francisco | 5 |
| #4 | Scasso Alejandro | 5 |
| #5 | Stefano Francisco Jose Evarist | 4 |
| #6 | Gabach Roberto Juan | 3 |
| #7 | Biali Fabian Isaac | 2 |
| #8 | Stefano Francisco José Evaristo | 2 |
| #9 | Stefano Francisco Jose Evaristo | 2 |
| #10 | Stefano Francisco Jose E | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2016096840A1 | A device for the transdermal delivery of rotigotine | |
| WO2013027052A1 | A device for the transdermal delivery of alkaline compounds that are susceptible to degradation in their free base form | |
| CA2678320A1 | Transdermal drug delivery system for liquid active ingredient | |
| GB0229836D0 | Transdermal delivery device for the administration of fentanyl | |
| CA2366852A1 | Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix | |
| US6465005B1 | Inhibition of crystallization in transdermal devices |